Saracatinib

CAS : 379231-04-6

Ref. TR-S139350

Informations sur le produit

• Nom: Saracatinib
• Synonymes: N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine, 4-(6-Chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline, 4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, 7-[2-[4-Methylpiperazin-1-yl]ethoxy]-5-[[tetrahydropyran-4-yl]oxy]-4-[[6-chloro-2,3-methylenedioxyphenyl]amino]quinazoline, Azd 0530, Azd 530, Azd0530, N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
• CAS: 379231-04-6

Description

Applications An oral, selective dual inhibitor of Src and ABL kinase. It is a COVID19-related research product.
References Schweppe, R., et al.: J. Clin. Endocrinol., Metab., 94, 2199 (2009), Chen, Y., et al.: Clin. Canc. Res., 15, 3396 (2009), McDermott, U., et al.: Cancer Res., 70, 1625 (2010),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 542.03
• Formule: C₂₇H₃₂ClN₅O₅
• Couleur/Forme: Neat
• InChI: InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
• Code InChI: InChIKey=OUKYUETWWIPKQR-UHFFFAOYSA-N
• SMILES: CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1